We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRNY icon
2951
Kearny Financial
KRNY
$595M
$55K ﹤0.01%
4,595
-3,800
-45% -$48K
PCVX icon
2952
Vaxcyte
PCVX
$8.67B
$55K ﹤0.01%
2,460
-424
-15% -$8.68K
PNTG icon
2953
Pennant Group
PNTG
$1.38B
$55K ﹤0.01%
1,347
-709
-34% -$27.6K
PSEC icon
2954
Prospect Capital
PSEC
$1.15B
$55K ﹤0.01%
6,619
-31,614
-83% -$264K
RIGL icon
2955
Rigel Pharmaceuticals
RIGL
$778M
$55K ﹤0.01%
1,284
-432
-25% -$16.3K
RPAY icon
2956
Repay Holdings
RPAY
$317M
$55K ﹤0.01%
2,306
-5,492
-70% -$129K
NGM
2957
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$55K ﹤0.01%
2,793
+1,091
+64% +$25.5K
ENPC
2958
DELISTED
Executive Network Partnering Corporation
ENPC
$55K ﹤0.01%
5,690
-1,462
-20% -$14.3K
RDUS
2959
DELISTED
Radius Health, Inc.
RDUS
$55K ﹤0.01%
3,006
-1,086
-27% -$21.6K
MCF
2960
DELISTED
Contango Oil & Gas Co.
MCF
$55K ﹤0.01%
12,656
+877
+7% +$3.68K
AKYA
2961
DELISTED
Akoya BioSciences
AKYA
$54K ﹤0.01%
+2,798
New +$57.8K
ALEX
2962
DELISTED
Alexander & Baldwin
ALEX
$54K ﹤0.01%
2,946
-416
-12% -$7.67K
AYTU icon
2963
AYTU BioPharma
AYTU
$25.5M
$54K ﹤0.01%
539
+468
+659% +$54.9K
BRKL
2964
DELISTED
Brookline Bancorp
BRKL
$54K ﹤0.01%
3,574
-4,406
-55% -$70.5K
CWEN icon
2965
Clearway Energy Class C
CWEN
$6.78B
$54K ﹤0.01%
2,043
-21,275
-91% -$584K
EFC
2966
Ellington Financial
EFC
$1.72B
$54K ﹤0.01%
2,820
-8,402
-75% -$155K
ENTX icon
2967
Entera Bio
ENTX
$150M
$54K ﹤0.01%
9,008
-12,991
-59% -$48K
FROG icon
2968
JFrog
FROG
$10.7B
$54K ﹤0.01%
1,176
+511
+77% +$23K
FXI icon
2969
iShares China Large-Cap ETF
FXI
$4.35B
$54K ﹤0.01%
1,161
-3,244
-74% -$150K
GIII icon
2970
G-III Apparel Group
GIII
$1.48B
$54K ﹤0.01%
1,651
-3,076
-65% -$99.6K
GNL icon
2971
Global Net Lease
GNL
$1.95B
$54K ﹤0.01%
2,917
-6,279
-68% -$120K
HAPN
2972
Happen Inc
HAPN
$2.24B
$54K ﹤0.01%
2,968
-6,667
-69% -$104K
LCNB icon
2973
LCNB Corp
LCNB
$279M
$54K ﹤0.01%
3,287
+1,530
+87% +$26.9K
PGEN icon
2974
Precigen
PGEN
$2.51B
$54K ﹤0.01%
8,377
-568
-6% -$3.97K
CATC
2975
DELISTED
CAMBRIDGE BANCORP
CATC
$54K ﹤0.01%
646
+209
+48% +$17.8K
117 118
119
120 121

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.